Effect of region and hospital attribute on outcome of gastric patients treated with apatinib: Data from post-marketing phase IV study.

Zhong, HJ; Qin, SK; Li, J; Deng, WY; Wen, L; Wang, JS; Zhang, GF; Jia, TF; Yang, JW; Ba, Y; Bai, YX; Wang, M; Wang, L; Liu, LK; He, YF; Tao, M; Xie, CY; Ye, F; Wu, XY; Lin, XY

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):